← Open Payments lookup

JENNIFER LITTELL: Open Payments

NPI 1336568468 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,600 in 73 payments from 14 companies in 2025. Trend: 2023 $1,063 · 2024 $1,420 · 2025 $1,600

Food & beverage: $1,600
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP24$497
GlaxoSmithKline, LLC.19$372
Stryker Corporation1$140
Boehringer Ingelheim Pharmaceuticals, Inc.5$102
United Therapeutics Corporation4$98
Regeneron Healthcare Solutions, Inc.3$74
GENZYME CORPORATION3$69
Viatris Specialty LLC3$65
Verona Pharma, Inc.3$58
Baxter Healthcare2$34

Products named: NUCALA, FASENRA, DUPIXENT, FLOWTRIEVER, TRELEGY ELLIPTA, BREZTRI, TEZSPIRE, Tyvaso.

Industry payments across LA — which companies pay providers there.